Growth Trends Will Continue to Make Popular Stocks More Valuable

Sometimes, a company will be caught in a virtuous loop, where its rising share price attracts analyst upgrades. In turn, the shares rise again, prompting more analysts to turn bullish. While that can sometimes end up looking a little silly in hindsight, for the right company, it may be a sign that growth is taking off. That could be the case with a big growth story in the markets right now, especially when the virtuous cycle leads a company back to ...
Read More
|

Higher Prices? Higher Rewards for Shareholders

Some companies assume that when things are going well, that trend will continue forever. That can sometimes lead to unpleasant surprises. During last year’s pandemic, a number of companies cut or suspended dividends or share buybacks, for instance. However, companies in the commodity space tend to recognize the power of cycles. When things are going well, they may be more inclined to pass the good times on to shareholders rather than overinvest when times are good. Case in point? Royal Dutch Shell ...
Read More
|

Supply Chain Issues or Not, Retail Trends Will Likely Move Higher

The economy has been moving strongly past the pandemic, but concerns over inflation and supply chain disruptions have led to some uncertainty. While markets are generally heading higher, one area is likely to continue plugging along at a steady and growing rate. That space? Retail. Pent-up consumer demand is coming out as the labor market looks to not only stabilize, but do so at higher wages. That bodes well to companies across the retail spectrum. Most investors would do well to focus ...
Read More
|

A New CEO Could Break this Stock Out of Its Stuck Range

There’s nothing wrong with a company trading in a range, moving up a little and down a little, but mostly unchanged over time. But investors who look for catalysts can likely find hints as to whether a company will break out of its range higher or lower. Right now, one range-bound stock is also one of the biggest out there. Shares of Amazon (AMZN) have been stuck in the low $3,000 range after a massive rally over the past few years. Now, ...
Read More
|

Another Share Drop Following Strong Earnings Points to a Rebound Opportunity

It’s a simple trading strategy: Find a company that’s performing well and just posted great quarterly earnings numbers. Then, if shares drop because the company’s guidance isn’t bullish enough, buy the dip and wait for the rebound, following the fundamentals. That’s as strategy likely to pay off well in this market throughout earnings season. One such trade has already presented itself in Walgreens Boots Alliance (WBA). The drugstore chain posted great growth, but shares got knocked down last week following earnings anyway ...
Read More
|

Continued Upside in Value Stocks Could Reward Investors with Some Fizz From this Flat Performer

The first half of the year saw a slowdown in tech stocks, and better relative strength in value names. While growth has started to rise in recent sessions, investors who continue to invest in both growth and value can do well in this market. Some of the best values may be in value names that have now underperformed over the past year. Any positive surprises in such a company may result in a jump higher in shares with low downside risk. One ...
Read More
|

Stocks In This Sector Are Firing on All Cylinders, and Rewarding Shareholders

A number of sectors are looking strong going into the back half of the year. In one sector, costs are going down, expenditures look likely to drop, and prices remain robust, which makes for an attractive move going forward. The sector? Oil and natural gas. A number of companies are looking good as OPEC is set to meet on production, with oil potentially capable of seeing oil hit $100 per barrel. Case in point is ConocoPhillips (COP). The energy giant just increased ...
Read More
|

Everyday Low Prices Come to the Prescription Drug Market

Even when inflation rates weren’t rising at multi-year highs, prices for some goods have been rising far higher than the national average. One of the biggest areas with increasingly higher prices has been in drug costs. Enter Walmart (WMT). The retail giant is now offering a private-label insulin. The diabetes drug is priced at nearly 50 percent lower than brand names, potentially saving users thousands of dollars per year. The company’s ReliOn NovoLog brand of insulin vials and pens has started being ...
Read More
|